Join MitoAction and Dr. Richard Boles for our November Mito Expert Series presentation titled: Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How...
Join MitoAction , Christine Stanley, Chief Director of Clinical Genomics at Variantyx and David Keane, Director of Rare Disorders at Variantyx, Inc. for our Monthly Mito Expert Series presentation...
Join MitoAction and David Keane from GeneDX for our December Monthly Mito Expert Series presentation titled: Mito Genetic Basics: Disease, Testing and Financial. About the Speaker: David Keane...
When: Dec 6, 2019 12:00 PM Eastern Time (US and Canada) Topic: Genetic Testing – Genome Sequencing: A-Z for Mitochondrial Disease Please click the link below to join the...
Join us with Dr. Sumit Parikh, Director of the Cleveland Clinic Neurogenetics, Metabolic and Mitochondrial Disease program, and past president of the Mitochondrial Medicine Society. Learn more about the 2014-2015...
Join MitoAction and Dr. Richard Frye to discuss the distinction between primary and secondary mitochondrial diagnosis. Some talking points will include: Primary mitochondrial disease (PMD) is ideally diagnosed by...
Tools for Testing Mitochondrial Disorders: The Latest Advances in Genetics and Genomics Guest speaker Dr. Richard Boles from Children’s Hospital Los Angeles and Courtagen Life Sciences, Inc. to discuss:...
Join MitoAction and Dr. Fran Kendall to discuss Direct to Consumer genetic testing (DTC testing) in detail. Some talking points will include: Strengths and limitations of DTC testing. Studies and...
For many years, muscle biopsy has been considered the “best” way to obtain an accurate diagnosis of mitochondrial disease. Muscle biopsy is costly, it is invasive, and is occasionally...
As a follow-up discussion to Dr. Fran Kendall’s presentation on “Muscle Biopsy Testing for Mitochondrial Disease”, MitoAction welcomes Dr. Steve Sommer of MEDomics to discuss testing for mitochondrial disease...